Table 2.
Scale scores at baseline and subsequent violence and self harm
| Harm to others | Harm to self | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |
AUC |
95% CI of AUC |
P |
OR |
95% CI of OR |
p |
AUC |
95% CI of AUC |
p |
OR |
95% CI of OR |
p |
||||
| |
|
lower |
upper |
|
|
lower |
upper |
|
|
lower |
upper |
|
|
lower |
upper |
|
| SAPROF* |
0.847 |
0.721 |
0.974 |
0.001 |
0.775 |
0.676 |
0.888 |
0.001 |
0.766 |
0.600 |
0.931 |
0.019 |
0.848 |
0.738 |
0.973 |
0.019 |
| START-S* |
0.776 |
0.653 |
0.900 |
0.001 |
0.903 |
0.845 |
0.964 |
0.002 |
0.644 |
0.454 |
0.833 |
0.207 |
0.957 |
0.891 |
1.028 |
0.227 |
| START-V |
0.823 |
0.707 |
0.940 |
0.001 |
1.139 |
1.057 |
1.226 |
0.001 |
0.654 |
0.456 |
0.853 |
0.175 |
1.052 |
0.978 |
1.131 |
0.176 |
| HCR-H |
0.836 |
0.747 |
0.924 |
0.001 |
1.226 |
1.033 |
1.454 |
0.020 |
0.822 |
0.683 |
0.960 |
0.001 |
1.178 |
0.998 |
1.391 |
0.053 |
| HCR-C |
0.794 |
0.693 |
0.951 |
0.001 |
1.530 |
1.186 |
1.974 |
0.001 |
0.814 |
0.617 |
1.0 |
0.001 |
1.603 |
1.116 |
2.303 |
0.011 |
| HCR-R |
0.809 |
0.693 |
0.924 |
0.001 |
1.712 |
1.265 |
2.317 |
0.001 |
0.790 |
0.658 |
0.921 |
0.001 |
1.502 |
1.077 |
2.094 |
0.016 |
| HCR-dynamic |
0.802 |
0.656 |
0.948 |
0.001 |
1.309 |
1.128 |
1.519 |
0.001 |
0.803 |
0.625 |
0.980 |
0.001 |
1.279 |
1.067 |
1.533 |
0.008 |
| HCR-20 total |
0.872 |
0.783 |
0.961 |
0.001 |
1.236 |
1.102 |
1.386 |
0.001 |
0.881 |
0.789 |
0.973 |
0.001 |
1.201 |
1.058 |
1.363 |
0.005 |
| S-RAMM-B |
0.766 |
0.636 |
0.895 |
0.002 |
1.488 |
1.154 |
1.918 |
0.002 |
0.655 |
0.459 |
0.852 |
0.172 |
1.248 |
0.939 |
1.659 |
0.126 |
| S-RAMM-C |
0.741 |
0.610 |
0.872 |
0.005 |
1.403 |
1.105 |
1.782 |
0.005 |
0.813 |
0.670 |
0.957 |
0.006 |
1.619 |
1.163 |
2.253 |
0.004 |
| S-RAMM-F |
0.669 |
0.526 |
0.812 |
0.05 |
1.108 |
0.951 |
1.290 |
0.190 |
0.619 |
0.451 |
0.787 |
0.295 |
1.075 |
0.894 |
1.293 |
0.444 |
| S-RAMM dynamic |
0.729 |
0.593 |
0.866 |
0.008 |
1.136 |
1.012 |
1.295 |
0.031 |
0.760 |
0.600 |
0.921 |
0.022 |
1.141 |
0.998 |
1.308 |
0.054 |
| S-RAMM total |
0.838 |
0.756 |
0.919 |
0.001 |
1.196 |
1.059 |
1.350 |
0.004 |
0.818 |
0.727 |
0.909 |
0.005 |
1.145 |
1.014 |
1.293 |
0.029 |
| GAF* |
0.813 |
0.651 |
0.974 |
0.001 |
0.909 |
0.860 |
0.960 |
0.001 |
0.855 |
0.649 |
1.0 |
0.002 |
0.908 |
0.850 |
0.970 |
0.004 |
| PANSS positive |
0.752 |
0.607 |
0.898 |
0.003 |
1.146 |
1.050 |
1.252 |
0.002 |
0.764 |
0.535 |
0.993 |
0.02 |
1.161 |
1.038 |
1.299 |
0.009 |
| PANSS negative |
0.639 |
0.488 |
0.791 |
0.106 |
1.060 |
0.985 |
1.141 |
0.119 |
0.656 |
0.472 |
0.840 |
0.170 |
1.057 |
0.961 |
1.163 |
0.256 |
| PANSS general |
0.725 |
0.574 |
0.877 |
0.009 |
1.073 |
1.016 |
1.134 |
0.012 |
0.823 |
0.673 |
0.972 |
0.005 |
1.101 |
1.027 |
1.180 |
0.007 |
| PANSS total |
0.711 |
0.577 |
0.866 |
0.014 |
1.035 |
1.009 |
1.062 |
0.009 |
0.770 |
0.569 |
0.971 |
0.017 |
1.042 |
1.008 |
1.078 |
0.015 |
| PANSS SAR |
0.832 |
0.730 |
0.934 |
0.001 |
1.509 |
1.217 |
1.872 |
0.001 |
0.846 |
0.728 |
0.965 |
0.002 |
1.408 |
1.118 |
1.772 |
0.004 |
| DUNDRUM-1 therapeutic security |
0.743 |
0.603 |
0.883 |
0.007 |
1.238 |
1.060 |
1.447 |
0.007 |
0.712 |
0.495 |
0.929 |
0.063 |
1.226 |
1.012 |
1.486 |
0.038 |
| DUNDRUM-3 programme completion |
0.832 |
0.727 |
0.937 |
0.001 |
1.294 |
1.097 |
1.525 |
0.002 |
0.750 |
0.596 |
0.904 |
0.028 |
1.184 |
1.003 |
1.396 |
0.046 |
| DUNDRUM-4 recovery | 0.728 | 0.605 | 0.853 | 0.011 | 1.226 | 1.029 | 1.461 | 0.023 | 0.713 | 0.557 | 0.905 | 0.043 | 1.227 | 0.977 | 1.540 | 0.079 |
Area under the curve (AUC) from receiver operating characteristics and unadjusted odds ratios (OR) for 100 in-patients. Six month prospective study, 13 incidents of violence to others, 7 incidents of self harm. Variables marked * (SAPROF, START-S, GAF) have AUC calculated such that smaller test scores indicate higher risk of the adverse events. Unadjusted odds ratios (OR) are given with Wald p values.